Representative before the EPO

Employment test 201 - 500 employees
Company dna regimbeau
operating since 1931
Headquarter in Paris and 8 offices
active in Legal Services and IP Consulting

Frédérique Faivre Petit has worked on the following 8 EPO patent applications which have been published in the last five years:

EP11305447

Process for identifying novel anti-inflammatory molecules with reduced direct transrepression of genes induced by glucocorticoids

IPC classification:
C12Q 1/68
Applicant:
Université de Strasbourg
Agent:
Frédérique Faivre Petit, Cabinet Regimbeau
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11305309

Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to a polyanionic polypeptide for the treatment of aids

IPC classification:
A61K 47/48, A61P 31/18, C07K 14/705
Agent:
Frédérique Faivre Petit, Cabinet Regimbeau
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP09851471

RECOMBINANT MEASLES VIRUS USEFUL AS BIVALENT VACCINE AGAINST MEASLES AND NIPAH VIRUS INFECTION

IPC classification:
A61K 35/76, A61K 39/155, A61K 39/295, A61K 39/395, A61P 31/14, C07K 16/10, C12N 7/00, C12N 15/09
Agent:
Frédérique Faivre Petit, Cabinet Regimbeau
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP09851470

RECOMBINANT MEASLES VIRUS USEFUL AS BIVALENT VACCINE AGAINST MEASLES AND MALARIA INFECTION

IPC classification:
A61K 35/76, A61K 39/015, A61K 39/395, A61P 31/14, A61P 33/06, C12N 7/00, C12N 15/09
Agent:
Frédérique Faivre Petit, Cabinet Regimbeau
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11305376

Shelf-stable food products and methods of making same

IPC classification:
A23C 9/13, A23L 3/3472, A23L 3/3517
Applicant:
Compagnie Gervais Danone
Agent:
Frédérique Faivre Petit, Cabinet Regimbeau
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP10790854

AGONISTS OF TLR4 AND 9 RECEPTORS FOR PREVENTING SEPTIC COMPLICATIONS OF POST-TRAUMATIC IMMUNE DEPRESSION IN PATIENTS HOSPITALIZED FOR SEVERE TRAUMA

IPC classification:
A61K 39/39
Applicant:
Université de Nantes
Applicant:
Centre Hospitalier Universitaire Nantes
Agent:
Frédérique Faivre Petit, Cabinet Regimbeau
Status:
PATENT GRANTED
EP10787813

A NEUROFILAMENT PEPTIDE FOR USE IN THE TREATMENT OF GLIOMA

IPC classification:
A61K 38/16, A61P 25/00, A61P 35/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université d'Angers
Applicant:
McGill University - The Royal Institution for the Advancement of Learning
Agent:
Frédérique Faivre Petit, Cabinet Regimbeau
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP10798671

DUAL PASTE DIRECT INJECTABLE BONE CEMENT PRECURSOR SYSTEMS AND METHODS OF MAKING SAME

IPC classification:
A61L 24/00, A61L 24/02, A61L 24/06, A61L 27/12, A61L 27/50
Applicant:
Howmedica Osteonics Corporation
Agent:
Frédérique Faivre Petit, Cabinet Regimbeau
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature